Se‐Woong Oh

526 total citations
15 papers, 450 citations indexed

About

Se‐Woong Oh is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Se‐Woong Oh has authored 15 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Se‐Woong Oh's work include RNA Interference and Gene Delivery (2 papers), GDF15 and Related Biomarkers (2 papers) and Ubiquitin and proteasome pathways (2 papers). Se‐Woong Oh is often cited by papers focused on RNA Interference and Gene Delivery (2 papers), GDF15 and Related Biomarkers (2 papers) and Ubiquitin and proteasome pathways (2 papers). Se‐Woong Oh collaborates with scholars based in South Korea, Austria and Ethiopia. Se‐Woong Oh's co-authors include Christian Hugo, Richard J. Johnson, George F. Schreiner, Duk‐Hee Kang, Katherine Gordon, J. Ashley Jefferson, Dontscho Kerjaschki, Jeremy Hughes, Marilda Mazzali and Pann‐Ghill Suh and has published in prestigious journals such as Blood, Gastroenterology and Cancer Research.

In The Last Decade

Se‐Woong Oh

14 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Se‐Woong Oh South Korea	5	215	176	108	64	45	15	450
Yuki Takazawa Japan	9	238 1.1×	230 1.3×	86 0.8×	97 1.5×	43 1.0×	10	541
Feng-Ying Lei China	15	201 0.9×	169 1.0×	64 0.6×	41 0.6×	33 0.7×	33	508
Ming-Zhi Zhang United States	8	222 1.0×	229 1.3×	50 0.5×	82 1.3×	108 2.4×	8	669
Angela Koudijs Netherlands	10	250 1.2×	130 0.7×	57 0.5×	75 1.2×	71 1.6×	18	607
Muhammed Kashif Germany	10	224 1.0×	192 1.1×	66 0.6×	78 1.2×	55 1.2×	14	809
Jun Zou China	13	143 0.7×	138 0.8×	71 0.7×	39 0.6×	32 0.7×	27	400
Yoshiki Higashijima Japan	14	362 1.7×	164 0.9×	58 0.5×	113 1.8×	69 1.5×	24	729
Muneharu Yamada Japan	13	196 0.9×	228 1.3×	114 1.1×	58 0.9×	14 0.3×	35	535
Jessica L. Friedrich United States	9	170 0.8×	314 1.8×	98 0.9×	99 1.5×	28 0.6×	10	557
Liangxiang Xiao China	9	433 2.0×	341 1.9×	107 1.0×	102 1.6×	59 1.3×	17	799

Countries citing papers authored by Se‐Woong Oh

Since Specialization

Citations

This map shows the geographic impact of Se‐Woong Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Se‐Woong Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Se‐Woong Oh more than expected).

Fields of papers citing papers by Se‐Woong Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Se‐Woong Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Se‐Woong Oh. The network helps show where Se‐Woong Oh may publish in the future.

Co-authorship network of co-authors of Se‐Woong Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Se‐Woong Oh. A scholar is included among the top collaborators of Se‐Woong Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Se‐Woong Oh. Se‐Woong Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lee, Jae‐Won, Eunjung Lee, Hanna S. Hong, et al.. (2025). Abstract 6084: YH32364 (ABL104), a bispecific antibody against EGFR and 4-1BB, demonstrates potent anti-tumor efficacy through tumor-directed 4-1BB agonism. Cancer Research. 85(8_Supplement_1). 6084–6084.

Lee, Eunjung, Minji Choi, Juyoung Park, et al.. (2024). Abstract 6354: The HER2/4-1BB bispecific antibody, YH32367 (ABL105) demonstrates optimal efficacy and safety for HER2-expressing tumors and exhibits synergistic efficacy when combined with anti-PD-L1. Cancer Research. 84(6_Supplement). 6354–6354. 1 indexed citations

Lim, Seyoung, et al.. (2022). 235-LB: YH34160, a Novel Long-Acting GDF15 Fusion Protein, Exerts Potent and Sustained Body Weight Loss in Rodent Obesity Models. Diabetes. 71(Supplement_1). 4 indexed citations

Lim, Seyoung, et al.. (2021). 217-LB: YH34160, a Novel Long-Acting GDF15 Fusion Protein, Elicits Potent and Sustained Body Weight Loss in Obese Animal Models. Diabetes. 70(Supplement_1). 1 indexed citations

Koo, Hyun-Mo, et al.. (2019). Abstract 3915: YH25248, a selective PI3K delta inhibitor, shows synergistic effect with an anti-PD-L1 antibody. Cancer Research. 79(13_Supplement). 3915–3915. 1 indexed citations

Kim, Dohoon, Jun Hwan Kim, Hyun Ho Choi, et al.. (2019). SAT-350-YH25724, a novel long-acting GLP-1/FGF21 dual agonist, exhibits marked anti-fibrotic effects in different experimental models of liver fibrosis. Journal of Hepatology. 70(1). e793–e793. 1 indexed citations

Jeong, Eun Jeong, et al.. (2016). Sa1708 YH12852, a Novel, Potent and Highly Selective 5-HT4 Receptor Agonist, Accelerates Gastric Emptying and Small Intestinal Transit in Guinea Pigs and Monkeys. Gastroenterology. 150(4). S352–S353. 1 indexed citations

Oh, Se‐Woong, et al.. (2013). Tu1827 Yh4808, a Potent, Highly Selective K+-Competitive Acid Blocker, Suppressed Rat Acute Reflux Esophagitis More Effectively Than Esomeprazole. Gastroenterology. 144(5). S–857. 3 indexed citations

Oh, Se‐Woong, Jung Bok Lee, Bora Kim, et al.. (2012). Peptidomimetic small-molecule compounds promoting cardiogenesis of stem cells. Archives of Pharmacal Research. 35(11). 1979–1988. 11 indexed citations

10.

Kim, Sung-Doo, Eun‐Hye Hur, Se‐Woong Oh, et al.. (2011). Abstract 4518: Effects of a novel small molecule inhibitor of Wnt signal pathway, CWP232291, on primary tumor cells from patients with malignant hematologic diseases. Cancer Research. 71(8_Supplement). 4518–4518. 5 indexed citations

11.

Jung, Jieun, et al.. (2010). Abstract LB-176: Discovery of CWP232291: A novel and potent small molecule inhibitor of Wnt signaling in hematological malignacies. Cancer Research. 70(8_Supplement). LB–176. 2 indexed citations

12.

Jung, Jieun, et al.. (2010). Anti-Tumor Activity of Novel Small Molecule Wnt Signaling Inhibitor, CWP232291, In Multiple Myeloma. Blood. 116(21). 3038–3038. 8 indexed citations

13.

Choi, Jang Hyun, Yong Ryoul Yang, Seul Ki Lee, et al.. (2008). Potential Inhibition of PDK1/Akt Signaling by Phenothiazines Suppresses Cancer Cell Proliferation and Survival. Annals of the New York Academy of Sciences. 1138(1). 393–403. 48 indexed citations

14.

Briaud, Isabelle, et al.. (2008). Therapeutic Potential of Small Molecule Inhibitor of Wnt Signaling in Acute Myelogenous Leukemia. Blood. 112(11). 4001–4001. 3 indexed citations

15.

Kang, Duk‐Hee, Se‐Woong Oh, Christian Hugo, et al.. (2001). Impaired Angiogenesis in the Remnant Kidney Model. Journal of the American Society of Nephrology. 12(7). 1434–1447. 361 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact